Eylea aflibercept ophthalmic solution regulatory update

Japan approved Eylea aflibercept from Bayer to treat diabetic macular edema (DME). The human fusion protein that binds all forms of VEGF-A and placental growth factor ( PGF; PlGF) is approved in Ja...